{"id":781843,"date":"2023-09-05T09:33:55","date_gmt":"2023-09-05T13:33:55","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\/"},"modified":"2023-09-05T09:33:55","modified_gmt":"2023-09-05T13:33:55","slug":"lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\/","title":{"rendered":"Lisata Therapeutics Announces Participation in Upcoming Conferences in September"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BASKING RIDGE, N.J., Sept.  05, 2023  (GLOBE NEWSWIRE) &#8212; Lisata Therapeutics, Inc. (Nasdaq: LSTA) (\u201cLisata\u201d or the \u201cCompany\u201d), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, PhD, Chief Executive Officer of Lisata, will present at two upcoming conferences in September. Details of the events are as follows:<\/p>\n<p>\n        <strong><br \/>\n          <em>H.C. Wainwright\u00a025<\/em><br \/>\n        <\/strong><br \/>\n        <sup><br \/>\n          <strong><br \/>\n            <em>t<\/em><br \/>\n          <\/strong><br \/>\n        <\/sup><br \/>\n        <sup><br \/>\n          <strong><br \/>\n            <em>h<\/em><br \/>\n          <\/strong><br \/>\n        <\/sup><br \/>\n        <strong><br \/>\n          <em> Annual Global Investment Conference<\/em><br \/>\n        <\/strong>\n      <\/p>\n<p>September 11-13 | New York City, NY<\/p>\n<p>Dr. Mazzo\u2019s presentation will be available on-demand on September 11, 2023, at 7:00 a.m. Eastern Time. Management will also participate in one-on-one meetings with investors on September 11<sup>th<\/sup>. For more information about the H.C. Wainwright 25<sup>th<\/sup> Annual Global Investment Conference, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yxouPByk7P50KD9nYh5CH7EREbnD4Zq0FKiQqTAM8_l7gNAVciLinoxBDgxyGPz2ngZurW7lXZMKQSATx05jGK_2YolJ9cQQP4wroUFGkQr6jrqe0S_x4fumXuxkVK1R74vsQ2EO47U4pFTBpnwF1VdnA15I8f7IbZSaLEGBgeU=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/hcwevents.com\/annualconference\/#toggle-id-5<\/a>.<\/p>\n<p>\n        <strong><br \/>\n          <em>LSX World Congress USA<\/em><br \/>\n        <\/strong>\n      <\/p>\n<p>September 13-14 | Boston, MA<\/p>\n<p>Dr. Mazzo will deliver a live presentation on Thursday, September 14, 2023, at 11:00 a.m. Eastern Time. Management will also participate in one-on-one meetings with investors on September 14<sup>th<\/sup>. For more information about the LSX World Congress USA, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yxouPByk7P50KD9nYh5CHyw8tcF4VII35f8zuQN99WIZbpC-7y5JM2CJqv_rlUkJ1QJD-tgboBAAsCXXT9RVzgYgaF1FgzSyisRK9duknx_06Pp913mL8brCTjQgH4jJ_V5-hYrhknSIzQHr2Y0u3A==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.lsxleaders.com\/lsx-usa-congress<\/a>.<\/p>\n<p>\n        <strong>About Lisata Therapeutics<\/strong>\n      <\/p>\n<p>Lisata Therapeutics is a <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=y8BpdHqk33ac8250Y-D5XRo6y8kBIsWiztG_9_xzhPzWO4_5w12daWqHifFZJENsHiCfzre7o45uxDUQfzaLTWpHiXUxnkF8FXvDqRMVtTf0tBaVeSHNvf9pc0SIdNrSy4LLlMXruQoCywSWCTWbVcMWzhNyxLg_QkTgEPeFsaQ=\" rel=\"nofollow noopener\" target=\"_blank\">clinical-stage pharmaceutical company<\/a> dedicated to the discovery, development and commercialization of innovative therapies for the treatment of <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SXp9BI4_IzuUULtCwGfHs1JNLnELqkSuRI2soHqf7QyD301l80IDdgfPfZONdCEZs5I18hiNbSgRtvF496-EZmRELT-2dxWFMllWNFnOxXFXlwDZ0-dFWnGAvxUxouh7nsJ1YBosjn_-OHKv-pGXfw==\" rel=\"nofollow noopener\" target=\"_blank\">advanced solid tumors<\/a> and other major diseases. Lisata\u2019s lead product candidate, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6RhMJY83ht96F-K5V-yzCZIZMOpXVg_hyaUfqpa0MwbOELPe6AH1ZvYsED7Vau0OtOlLpsQWZUXxJDjoStbi6f5SYw2NBS4OzN-rB2SfZwYm4QSo0svpKXwClZ4bvDayq-I7yYkdjVsqeU-pdnkFZPgi0BkclxW8cHViEcfQrv4=\" rel=\"nofollow noopener\" target=\"_blank\">LSTA1<\/a>, is an investigational drug designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate solid tumors more effectively. Based on Lisata\u2019s CendR Platform\u00ae Technology, Lisata has already established noteworthy commercial and R&amp;D partnerships. The Company expects to announce numerous clinical study and business milestones over the next two years and has projected that its current business and development plan is funded with available capital through these milestones and into early 2026. For more information on the Company, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FzhgaGMwhXyktEoQbgUKay0sG_9xaYpgRmwuSwTNJFURolo5RwvvvPxholM83WtHHkyD3AEPTUdW7oESGa4l7g==\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.lisata.com<\/u><\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>Investors and Media:<\/p>\n<p>Lisata Therapeutics, Inc.<br \/>John Menditto<br \/>Vice President, Investor Relations and Corporate Communications<br \/>Phone:\u00a0908-842-0084<br \/>Email:\u00a0jmenditto@lisata.com<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNTU3MCM1Nzk1NzAwIzIwMjExNTI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NjEwMmEwY2ItYzE3OS00NmM0LWJlMDUtM2M5ZTYzZjJkOWUxLTEwMzI4NjY=\/tiny\/Lisata-Therapeutics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BASKING RIDGE, N.J., Sept. 05, 2023 (GLOBE NEWSWIRE) &#8212; Lisata Therapeutics, Inc. (Nasdaq: LSTA) (\u201cLisata\u201d or the \u201cCompany\u201d), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, PhD, Chief Executive Officer of Lisata, will present at two upcoming conferences in September. Details of the events are as follows: H.C. Wainwright\u00a025 t h Annual Global Investment Conference September 11-13 | New York City, NY Dr. Mazzo\u2019s presentation will be available on-demand on September 11, 2023, at 7:00 a.m. Eastern Time. Management will also participate in one-on-one meetings with investors on September 11th. For more information about the H.C. Wainwright 25th Annual Global Investment Conference, please visit &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lisata Therapeutics Announces Participation in Upcoming Conferences in September&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-781843","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lisata Therapeutics Announces Participation in Upcoming Conferences in September - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lisata Therapeutics Announces Participation in Upcoming Conferences in September - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BASKING RIDGE, N.J., Sept. 05, 2023 (GLOBE NEWSWIRE) &#8212; Lisata Therapeutics, Inc. (Nasdaq: LSTA) (\u201cLisata\u201d or the \u201cCompany\u201d), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, PhD, Chief Executive Officer of Lisata, will present at two upcoming conferences in September. Details of the events are as follows: H.C. Wainwright\u00a025 t h Annual Global Investment Conference September 11-13 | New York City, NY Dr. Mazzo\u2019s presentation will be available on-demand on September 11, 2023, at 7:00 a.m. Eastern Time. Management will also participate in one-on-one meetings with investors on September 11th. For more information about the H.C. Wainwright 25th Annual Global Investment Conference, please visit &hellip; Continue reading &quot;Lisata Therapeutics Announces Participation in Upcoming Conferences in September&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-05T13:33:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNTU3MCM1Nzk1NzAwIzIwMjExNTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lisata Therapeutics Announces Participation in Upcoming Conferences in September\",\"datePublished\":\"2023-09-05T13:33:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\\\/\"},\"wordCount\":334,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNTU3MCM1Nzk1NzAwIzIwMjExNTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\\\/\",\"name\":\"Lisata Therapeutics Announces Participation in Upcoming Conferences in September - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNTU3MCM1Nzk1NzAwIzIwMjExNTI=\",\"datePublished\":\"2023-09-05T13:33:55+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNTU3MCM1Nzk1NzAwIzIwMjExNTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNTU3MCM1Nzk1NzAwIzIwMjExNTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lisata Therapeutics Announces Participation in Upcoming Conferences in September\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lisata Therapeutics Announces Participation in Upcoming Conferences in September - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\/","og_locale":"en_US","og_type":"article","og_title":"Lisata Therapeutics Announces Participation in Upcoming Conferences in September - Market Newsdesk","og_description":"BASKING RIDGE, N.J., Sept. 05, 2023 (GLOBE NEWSWIRE) &#8212; Lisata Therapeutics, Inc. (Nasdaq: LSTA) (\u201cLisata\u201d or the \u201cCompany\u201d), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, PhD, Chief Executive Officer of Lisata, will present at two upcoming conferences in September. Details of the events are as follows: H.C. Wainwright\u00a025 t h Annual Global Investment Conference September 11-13 | New York City, NY Dr. Mazzo\u2019s presentation will be available on-demand on September 11, 2023, at 7:00 a.m. Eastern Time. Management will also participate in one-on-one meetings with investors on September 11th. For more information about the H.C. Wainwright 25th Annual Global Investment Conference, please visit &hellip; Continue reading \"Lisata Therapeutics Announces Participation in Upcoming Conferences in September\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-05T13:33:55+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNTU3MCM1Nzk1NzAwIzIwMjExNTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lisata Therapeutics Announces Participation in Upcoming Conferences in September","datePublished":"2023-09-05T13:33:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\/"},"wordCount":334,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNTU3MCM1Nzk1NzAwIzIwMjExNTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\/","name":"Lisata Therapeutics Announces Participation in Upcoming Conferences in September - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNTU3MCM1Nzk1NzAwIzIwMjExNTI=","datePublished":"2023-09-05T13:33:55+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNTU3MCM1Nzk1NzAwIzIwMjExNTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNTU3MCM1Nzk1NzAwIzIwMjExNTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-announces-participation-in-upcoming-conferences-in-september\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lisata Therapeutics Announces Participation in Upcoming Conferences in September"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/781843","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=781843"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/781843\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=781843"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=781843"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=781843"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}